Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Conen

Showing results (271-280 of 363) with videos related to

Pageof 37
Sort By:
Swiss Medical Weekly|January 29, 2025
Impact of atrial fibrillation on productivity in working-age patients: an analysis of Swiss-AF prospective cohort study dataHelena Aebersold, Fabienne Foster-Witassek, Sina Amberg, et al.
JACC. Advances|March 27, 2025
Polygenic Risk Scores in Myocardial Injury After Noncardiac Surgery: A VISION SubstudyAnn Le, Guillaume Paré, P J Devereaux, et al.
BMJ Open|September 14, 2023
Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controlsHelena Aebersold, Fabienne Foster-Witassek, Miquel Serra-Burriel, et al.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
Heart (British Cardiac Society)|November 4, 2022
Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohortHelena Aebersold, Miquel Serra-Burriel, Fabienne Foster-Wittassek, et al.
Frontiers in Cardiovascular Medicine|September 24, 2024
Blood pressure, brain lesions and cognitive decline in patients with atrial fibrillationDésirée Carmine, Stefanie Aeschbacher, Michael Coslovsky, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 24, 2021
Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysisWilliam F McIntyre, Maria E Vadakken, Anand S Rai, et al.
Canadian Journal of Kidney Health and Disease|July 17, 2023
Effect of Colchicine on the Risk of Perioperative Acute Kidney Injury: Clinical Protocol of a Substudy of the Colchicine for the Prevention of Perioperative Atrial Fibrillation Randomized Clinical TrialAmit X Garg, Meaghan Cuerden, Juan Cata, et al.
Journal of the American Heart Association|August 5, 2020
Heart Rate Variability Triangular Index as a Predictor of Cardiovascular Mortality in Patients With Atrial FibrillationPeter Hämmerle, Christian Eick, Steffen Blum, et al.
Open Heart|February 1, 2024
Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohortHelena Aebersold, Fabienne Foster-Witassek, Stefanie Aeschbacher, et al.
Pageof 37

Showing results (271-280 of 363) with videos related to

Sort By:
Pageof 37
Swiss Medical Weekly|January 29, 2025
Impact of atrial fibrillation on productivity in working-age patients: an analysis of Swiss-AF prospective cohort study dataHelena Aebersold, Fabienne Foster-Witassek, Sina Amberg, et al.
JACC. Advances|March 27, 2025
Polygenic Risk Scores in Myocardial Injury After Noncardiac Surgery: A VISION SubstudyAnn Le, Guillaume Paré, P J Devereaux, et al.
BMJ Open|September 14, 2023
Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controlsHelena Aebersold, Fabienne Foster-Witassek, Miquel Serra-Burriel, et al.
Circulation|November 21, 2014
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trialChristoph Kaiser, Soeren Galatius, Raban Jeger, et al.
Heart (British Cardiac Society)|November 4, 2022
Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohortHelena Aebersold, Miquel Serra-Burriel, Fabienne Foster-Wittassek, et al.
Frontiers in Cardiovascular Medicine|September 24, 2024
Blood pressure, brain lesions and cognitive decline in patients with atrial fibrillationDésirée Carmine, Stefanie Aeschbacher, Michael Coslovsky, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 24, 2021
Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysisWilliam F McIntyre, Maria E Vadakken, Anand S Rai, et al.
Canadian Journal of Kidney Health and Disease|July 17, 2023
Effect of Colchicine on the Risk of Perioperative Acute Kidney Injury: Clinical Protocol of a Substudy of the Colchicine for the Prevention of Perioperative Atrial Fibrillation Randomized Clinical TrialAmit X Garg, Meaghan Cuerden, Juan Cata, et al.
Journal of the American Heart Association|August 5, 2020
Heart Rate Variability Triangular Index as a Predictor of Cardiovascular Mortality in Patients With Atrial FibrillationPeter Hämmerle, Christian Eick, Steffen Blum, et al.
Open Heart|February 1, 2024
Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohortHelena Aebersold, Fabienne Foster-Witassek, Stefanie Aeschbacher, et al.
Pageof 37